April 2025
1. YANG Y, Liu W, Zhang Z, Zhang Y, et al
   Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in autoimmune diseases.
   J Autoimmun. 2025;153:103414.
   

   >> Share

   
   January 2025
2. LI J, Xie Z, Yang L, Guo K, et al
   The impact of gut microbiome on immune and metabolic homeostasis in type 1 diabetes: Clinical insights for prevention and treatment strategies.
   J Autoimmun. 2025;151:103371.
   

   >> Share

   
   
3. AROWOSEGBE A, Guo Z, Vanderleeden E, Derr AG, et al
   Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats.
   J Autoimmun. 2025;151:103358.
   

   >> Share

   
   April 2024
4. DO JS, Arribas-Layton D, Juan J, Garcia I, et al
   The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation.
   J Autoimmun. 2024;146:103228.
   

   >> Share

   
   March 2024
5. GARCIA-LOZA I, Perna-Barrull D, Aguilera E, Almenara-Fuentes L, et al
   Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
   J Autoimmun. 2024;145:103196.
   

   >> Share

   
   October 2023
6. KISHIMOTO TK, Fournier M, Michaud A, Rizzo G, et al
   Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
   J Autoimmun. 2023;140:103125.
   

   >> Share

   
   August 2023
7. POYSTI S, Silojarvi S, Brodnicki TC, Catterall T, et al
   Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
   J Autoimmun. 2023;140:103090.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share